Glyburide clinical trials
Also written Glibenclamide, RP-1127, Micronase and Diabeta.
How each study uses Glyburide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Glyburide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 1 May 1984 · MICRONASE · NDA 017498 (FDA, Drugs@FDA)
- European Union
- 24 May 2018 · Amglidia · EMEA/H/C/004379 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
In one entry with another drug
Given together, or one or the other
- Glyburide/Metformin 5 mg/500 mg Tablets
- 2
Studies by the year they started
66 studies that test it; most in 2014 (6)
| Year | Studies |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 5 |
| 2003 | 5 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 3 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 22 · Other 44
Remedy Pharmaceuticals, Inc. (5) · Assistance Publique - Hôpitaux de Paris (4) · Actavis Inc. (3) · Teva Pharmaceuticals USA (2) · University of Texas Southwestern Medical Center (2) · Novo Nordisk A/S (2) · Beijing Tiantan Hospital (2) · Hospital de Clinicas de Porto Alegre (2)
Often tested with
Tested in the same studies.
Metformin (13) · Glucovance (3) · Insulin (3) · Rosiglitazone (3) · Repaglinide (2) · Vildagliptin (2) · DBPR108 (1) · Valsartan (1)
Related medicines
As reviewed, each with the page that says it.
- One of Hypoglycemic Agents source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Glyburide is the comparator. A study of two new drugs counts under both.
Reaching primary completion within a year · 1
Studies that test Glyburide.
- May 2027Spinal Cord Injury Neuroprotection With GlyburidePhase 1 · Francis Farhadi
Studies
Open first, then newest update. How each study uses Glyburide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 66
- Comparison of Metformin Versus Glyburide for Blood Sugar Control in Women With Gestational DiabetesRecruitingPhase 4Nishtar Medical UniversityNCT07802561Written as GlyburideHow we know
- Spinal Cord Injury Neuroprotection With GlyburideRecruitingPhase 1Francis FarhadiNCT05426681Written as GlyBURIDE Oral TabletHow we know
- OER Glibenclamide for Neuropathic Pain in Multiple SclerosisNot yet recruitingPhase 1University of Maryland, BaltimoreNCT07221799Written as glibenclamideHow we know
- Comparison Between Metformin and Glyburide in the Management of Gestational DiabetesNot yet recruitingNot applicableAssiut UniversityNCT06589141Written as GlyBURIDE 2.5 MG Oral TabletHow we know
- Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)CompletedPhase 2Assistance Publique - Hôpitaux de ParisNCT05687500Written as GlibenclamideHow we know
- Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)CompletedPhase 1/2Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT01329016Written as GlyburideHow we know
- Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes MellitusCompletedPhase 2Assistance Publique - Hôpitaux de ParisNCT00610038Written as glibenclamideHow we know
- Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP ChannelsCompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT02375828Written as GlibenclamideHow we know
- Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational DiabetesCompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT01731431Written as GlyburideHow we know
- Metabolic Analysis for Treatment Choice in Gestational Diabetes MellitusCompletedPhase 4Maisa N. Feghali, MDNCT03029702Written as GlyburideHow we know
- A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain ContusionTerminatedPhase 2Remedy Pharmaceuticals, Inc.NCT03954041Written as BIIB093How we know
- Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric InfarctionTerminatedPhase 3Remedy Pharmaceuticals, Inc.NCT02864953Written as BIIB093How we know
- Glyburide Advantage in Malignant Edema and Stroke PilotCompletedPhase 1/2Remedy Pharmaceuticals, Inc.NCT01268683Written as Glyburide for InjectionHow we know
- Metformin Compared to Glyburide in Gestational DiabetesCompletedNot applicableUniversity of New MexicoNCT00965991Written as GlyburideHow we know
- Glyburide Advantage in Malignant Edema and Stroke - Remedy PharmaceuticalsCompletedPhase 2Remedy Pharmaceuticals, Inc.NCT01794182Written as Glyburide for InjectionHow we know
- Glyburide (RP-1127) for Traumatic Brain Injury (TBI)CompletedPhase 2Remedy Pharmaceuticals, Inc.NCT01454154Written as GlyburideHow we know
- Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, FedCompletedPhase 1Teva Pharmaceuticals USANCT00835991Written as Glyburide/Metformin 5 mg/500 mg TabletsHow we know
- Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, FastingCompletedPhase 1Teva Pharmaceuticals USANCT00836472Written as Glyburide/Metformin 5 mg/500 mg TabletsHow we know
- Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 DiabetesTerminatedPhase 3Novo Nordisk A/SNCT00267683Written as glibenclamideHow we know
- Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral EmbolismCompletedPhase 2/3Nanfang Hospital, Southern Medical UniversityNCT03284463Written as GlibenclamideHow we know
See all 66 studies that test Glyburide →
Given beside what is tested · 6 — Glyburide is usual care or a partner of the new treatment
- The Hemodynamic Effects of PACAP38 After Glibenclamide Administration in Healthy VolunteersCompletedNot applicableDanish Headache CenterNCT04960657Written as glibenclamideHow we know
- Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive SubjectsCompletedPhase 4University of Campinas, BrazilNCT03089333Written as Glibenclamide 5Mg TabletHow we know
- A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With SulfonylureasCompletedPhase 3AstraZenecaNCT00313313Written as GlyburideHow we know
- Bioavailability of BI 1356 and Glyburide in Healthy Male and Female VolunteersCompletedPhase 1Boehringer IngelheimNCT02183428Written as GlyburideHow we know
- Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.CompletedPhase 3TakedaNCT00286468Written as Alogliptin and glyburideHow we know
- Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.TerminatedPhase 3TakedaNCT00759720Written as TAK-559 and glyburideHow we know
As the comparator · 19 — what is tested is compared with Glyburide
- Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM PatientsNot yet recruitingPhase 3University of ZambiaNCT05688332Written as Glibenclamide + MetforminHow we know
- Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DMCompletedPhase 4The University of Texas Health Science Center at San AntonioNCT01107717Written as metformin, glyburide and glargineHow we know
- Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial ArteryCompletedPhase 4University of Campinas, BrazilNCT02919345Written as Glibenclamide 5 mgHow we know
- Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)CompletedPhase 4Merck Sharp & Dohme LLCNCT02318693Written as GlibenclamideHow we know
- Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 DiabetesCompletedPhase 3Azienda Ospedaliero-Universitaria di ParmaNCT01822548Written as GlibenclamideHow we know
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00393718Written as glibenclamideHow we know
- Effect of Repaglinide on Postprandial Lipemia in Type 2 DiabetesCompletedPhase 4Novo Nordisk A/SNCT01605773Written as glyburideHow we know
- Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over StudyCompletedPhase 4Khoo Teck Puat HospitalNCT02201602Written as GlibenclamideHow we know
- Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes MellitusStatus unknownPhase 1Al-Neelain UniversityNCT01319734Written as glyburideHow we know
- Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic PatientsCompletedPhase 4St. Paul Heart ClinicNCT00123643Written as glyburideHow we know
- Safety Study of Pioglitazone Compared To Glyburide on Liver FunctionCompletedPhase 4TakedaNCT00494312Written as GlyburideHow we know
- Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac DiseaseCompletedPhase 3TakedaNCT00521742Written as GlyburideHow we know
- Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart FailureTerminatedPhase 3TakedaNCT00521820Written as GlyburideHow we know
- Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.CompletedPhase 3TakedaNCT00286468Written as Alogliptin and glyburideHow we know
- Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.TerminatedPhase 3TakedaNCT00759720Written as TAK-559 and glyburideHow we know
- A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes MellitusTerminatedPhase 2Eli Lilly and CompanyNCT01029795Written as GlyburideHow we know
- Evaluation of Cissus Verticillata L. Infusion in Controlling Type 2 DiabetesCompletedPhase 1/2Federal University of ParaíbaNCT01145534Written as glibenclamideHow we know
- Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.CompletedPhase 4TakedaNCT00770835Written as Glibenclamide and MetforminHow we know
- Insulin Glargine in Type 2 Diabetic PatientsCompletedPhase 4SanofiNCT00347100Written as GlyburideHow we know
Codes
What other systems call Glyburide · ClinicalTrials.gg INT007553
- MeSH (NLM) D005905GlyburideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) SX6K58TVWCGLYBURIDEConfirmed FDA, NLM, Wikidata
- RxNorm 4815Confirmed FDA, Wikidata
- Wikidata Q420626glyburideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29076GlyburideOne source FDA
- DrugBank DB01016One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D005905 | Glyburide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | SX6K58TVWC | GLYBURIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 4815 | — | Confirmed FDA, Wikidata |
| Wikidata | Q420626 | glyburide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29076 | Glyburide | One source FDA |
| DrugBank | DB01016 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.